Chorioamnionitis: Observation of at Risk Infants vs Standard Care (CHORIS-RCT)
Chorioamnionitis, Early Onset Neonatal Sepsis, Sepsis of the Newborn
About this trial
This is an interventional prevention trial for Chorioamnionitis focused on measuring Chorioamnionitis, Early onset neonatal sepsis, Antibiotics, Clinical observation
Eligibility Criteria
Inclusion Criteria:
- asymptomatic newborns born at term (>= 37 weeks of gestational age)
Exclusion Criteria:
- preterm newborns (< 37 weeks gestational age)
- sepsis-related signs of symptoms at birth
- intensive care admittance
Sites / Locations
- Institute for Maternal and Child Health IRCCS Burlo Garofolo
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Clinical observation
Standard management
Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. They will receive a limited evaluation (blood culture, complete blood count), and a clinical observation. Antibiotics will be started only if sepsis-related signs or symptoms are present.
Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. The will receive a limited evaluation (blood culture, complete blood count), a clinical observation and antibiotics at birth.